11:51 IST
BSE
Board Meeting Date
Epigral Board Meeting Date
Epigral Ltd scheduled a board meeting for July 27, 2026. The board will consider the company's first quarter unaudited financial results.
Epigral Ltd
- Share price
- ₹1,019.90
- Market cap
- ₹4,400 Cr
- Revenue (annual)
- ₹2,527 Cr
- Net profit (annual)
- ₹332.0 Cr
- P/E (TTM)
- 16.2×Sector 37.2×
- Promoter holding
- 68.83%+0.00% QoQ
- FII holding
- 1.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 7Financial Results 4Annual General Meeting 4Board Meeting Date 3Results Update 2Other Announcement 2Dividend 2Credit Rating 2Capacity Expansion 2Price Movement Clarification 1Merger & Restructuring 1Management Change 1
Time
3 announcements with these filters
12:41 IST
NSE
Board Meeting Date
Epigral Board Meeting Date
Epigral Limited has scheduled a Board Meeting for May 2, 2026, to approve audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also consider a final dividend recommendation. The trading window remains closed until May 4, 2026.
12:18 IST
BSE
Board Meeting Date
Epigral Board Meeting Date
Epigral Ltd has scheduled a Board Meeting for May 2, 2026. The directors will consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Additionally, the board will consider recommending a final dividend for the financial year.